|
 |
Dwight Kloth, PharmD, FCCP, BCOP
Director of Pharmacy
Fox Chase Cancer Center
Philadelphia, PA
Dwight D. Kloth, earned his PharmD and completed a clinical pharmacy residency at the University of Southern California (USC) and Los Angeles County/USC Medical Center in Los Angeles, California. After completing his training, Dr. Kloth spent 9 years at the City of Hope National Medical Center in Duarte, California. In 1988, he moved to the University of Maryland Cancer Center in Baltimore, where he was the director of pharmacy from 1988 to 1992. He then moved to the Fox Chase Cancer Center in Philadelphia, where he is director of pharmacy. At FCCC he serves or has served on the Research Review Committee, Institutional Review Board, Intensive Care Unit Committee, and Infection Control Committee, among other committess, and is the secretary of the Pharmacy and Therapeutics Committee. Dr. Kloth has participated in the development of institutional antiemetic guidelines and is the FCCC representative to two national guidelines panels (Antiemetics and Myeloid Growth Factors) for the National Comprehensive Cancer Network (NCCN), of which Fox Chase Cancer Center is a founding member. He is an adjunct assistant clinical professor at Temple University and serves as an item writer and reviewer for the Pharmacotherapy board certification examination. His teaching and research have focused on antiemetic, antimicrobial, analgesic, and other supportive care issues in oncology patients. He has been principal or co-investigator in studies presented at ASCO meetings as well as numerous pharmacy meetings. He has also published articles in Pharmacotherapy, the American Journal of Health-System Pharmacists, and other journals and has given more than 100 invited presentation related to oncology, supportive care in oncology, and pharmacoeconomics.
|
|
Disclosure Policy
It is the policy of ArcMesa Educators to ensure balance, independence, objectivity, and scientific rigor in all its educational activities. All faculty/authors are expected to disclose any relevant financial relationships they may have with commercial interests in relation to this activity. These relationships, along with the educational content of this program, have been reviewed and any potential conflicts of interest have been resolved to the satisfaction of ArcMesa Educators.
Staff Disclosure Declarations
The employees of ArcMesa Educators have no financial relationships to disclose.
Faculty Disclosure Declarations
Dwight Kloth, PharmD, FCCP, BCOP Advisory Board or Review Panel Member and Speakers' Bureau- Amgen and MGI Pharma; Advisory Board Sanofi-Aventis
Printer settings may vary. Please use landscape layout option.
Copyright © 2006 ArcMesa Educators / CMEdiscovery.com. All rights reserved.
|